(6,15). Using the three-dimensional structure of DdlB of Escherichia coli (13) and VanA from Enterococcus faecium (32), site-directed mutagenesis studies have defined the residues responsible for substrate specificity (13,21,23,24,35).The existence of two D-Ala:D-Ala ligase genes has been previously reported in E. coli and Salmonella enterica serovar Typhimurium (41). In this work we provide evidence for the first time that vancomycin-resistant Enterococcus gallinarum possess at least three dipeptide ligase genes, two encoding D-Ala:D-Ala ligases and the third encoding a D-Ala:D-Ser ligase.
MATERIALS AND METHODSBacterial strains, plasmids, and growth conditions. Bacterial strains and plasmids used in this work are described in Table 1. Enterococci were grown in brain heart yeast extract (BHY) (Difco Laboratories, Detroit, Mich.) broth or on BHY agar. Vancomycin-dependent E. faecalis BM4320 (ddl mutant) (5) used for complementation studies was grown in BHY supplemented with vancomycin (10 g/ml); 150 ␥g of gentamicin (Sigma, Steinheim, Germany) per ml was added to the medium for pAT392-containing derivatives of this strain. E. coli XL1-Blue (7) was grown in Luria-Bertani (LB) (Difco Laboratories) broth or agar supplemented with gentamicin (8 g/ml) E. coli derivatives containing pAT392 (3). E. coli M15(pREP4) (Qiagen) was grown in LB agar or broth supplemented with kanamycin (50 g/ml). Ampicillin (100 g/ml) was added for pQE-30 (Qiagen)-containing derivatives.DNA manipulations, and plasmid construction and sequencing. E. gallinarum BM4174 total DNA was extracted as described previously (28). Cloning, digestion with restriction endonucleases (Boehringer GmbH, Mannheim, Germany), isolation of plasmid DNA (Wizard Plus SV Minipreps; Promega), ligation, and transformation were carried out by standard methods (33). The sequence of ddl2 was obtained from an insert in plasmid pCA8 that has been described previously